Improved methods for urinary atrazine mercapturate analysis-Assessment of an enzyme-linked immunosorbent assay (ELISA) and a novel liquid chromatography-mass spectrometry (LC-MS) method utilizing online solid phase extraction (SPE)

Marja E. Koivunen, Katja Dettmer, Roel Vermeulen, Berit Bakke, Shirley J. Gee, Bruce D. Hammock

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Elimination of interfering substances in urine by solid phase extraction (SPE) prior to analysis resulted in 10-fold improvement in the sensitivity of atrazine mercapturate (AM) enzyme-linked immunosorbent assay (ELISA) compared to previous reports. Of the two tested SPE systems, Oasis® HLB and MCX, the mixed-mode MCX gave good recoveries (82%) of AM in spiked samples measured by ELISA, whereas the reverse-phase HLB phase was not compatible with the immunochemical method. At relatively high concentrations of urinary AM (>20 ng mL-1), sample dilution was effective enough for the elimination of interfering substances. The new liquid chromatography-mass spectrometry (LC-MS) method developed for AM utilizes online-SPE with Oasis® HLB, column switching and a stable-isotope internal standard. The limit of quantification (0.05 ng mL-1) indicates improved sensitivity compared with most previously published LC-MS methods for AM. Validation of all three methods, LC-MS, ELISA + SPE and ELISA + dilution with spiked urine samples showed good correlation between the known and measured concentrations with R2 values of 0.996, 0.957 and 0.961, respectively. When a set (n = 70 plus 12 blind duplicates) of urine samples from farmers exposed to atrazine was analyzed, there was a good agreement (R2 = 0.917) between the log normalized data obtained by ELISA + SPE and LC-MS. High correlation among the data obtained by the two tested methods and the LC-MS method by the Center of Disease Control and Prevention (CDC), together with low variability among the blind duplicates, suggests that both methods reported here would be suitable for the analysis of urinary AM as a biomarker for human exposure of atrazine.

Original languageEnglish (US)
Pages (from-to)180-189
Number of pages10
JournalAnalytica Chimica Acta
Volume572
Issue number2
DOIs
StatePublished - Jul 21 2006

Fingerprint

Immunosorbents
Solid Phase Extraction
Liquid chromatography
atrazine
Liquid Chromatography
Mass spectrometry
liquid chromatography
Assays
Mass Spectrometry
mass spectrometry
Enzyme-Linked Immunosorbent Assay
assay
enzyme
Enzymes
Atrazine
urine
Urine
Dilution
oasis
Disease control

Keywords

  • Atrazine mercapturate
  • Enzyme-linked immunosorbent assay (ELISA)
  • Human biomonitoring
  • Liquid chromatography-mass spectrometry (LC-MS)
  • Online solid phase extraction
  • Solid phase extraction (SPE)

ASJC Scopus subject areas

  • Biochemistry
  • Analytical Chemistry
  • Spectroscopy
  • Environmental Chemistry

Cite this

Improved methods for urinary atrazine mercapturate analysis-Assessment of an enzyme-linked immunosorbent assay (ELISA) and a novel liquid chromatography-mass spectrometry (LC-MS) method utilizing online solid phase extraction (SPE). / Koivunen, Marja E.; Dettmer, Katja; Vermeulen, Roel; Bakke, Berit; Gee, Shirley J.; Hammock, Bruce D.

In: Analytica Chimica Acta, Vol. 572, No. 2, 21.07.2006, p. 180-189.

Research output: Contribution to journalArticle

@article{c68d877d683247ce90986ac71ad0a045,
title = "Improved methods for urinary atrazine mercapturate analysis-Assessment of an enzyme-linked immunosorbent assay (ELISA) and a novel liquid chromatography-mass spectrometry (LC-MS) method utilizing online solid phase extraction (SPE)",
abstract = "Elimination of interfering substances in urine by solid phase extraction (SPE) prior to analysis resulted in 10-fold improvement in the sensitivity of atrazine mercapturate (AM) enzyme-linked immunosorbent assay (ELISA) compared to previous reports. Of the two tested SPE systems, Oasis{\circledR} HLB and MCX, the mixed-mode MCX gave good recoveries (82{\%}) of AM in spiked samples measured by ELISA, whereas the reverse-phase HLB phase was not compatible with the immunochemical method. At relatively high concentrations of urinary AM (>20 ng mL-1), sample dilution was effective enough for the elimination of interfering substances. The new liquid chromatography-mass spectrometry (LC-MS) method developed for AM utilizes online-SPE with Oasis{\circledR} HLB, column switching and a stable-isotope internal standard. The limit of quantification (0.05 ng mL-1) indicates improved sensitivity compared with most previously published LC-MS methods for AM. Validation of all three methods, LC-MS, ELISA + SPE and ELISA + dilution with spiked urine samples showed good correlation between the known and measured concentrations with R2 values of 0.996, 0.957 and 0.961, respectively. When a set (n = 70 plus 12 blind duplicates) of urine samples from farmers exposed to atrazine was analyzed, there was a good agreement (R2 = 0.917) between the log normalized data obtained by ELISA + SPE and LC-MS. High correlation among the data obtained by the two tested methods and the LC-MS method by the Center of Disease Control and Prevention (CDC), together with low variability among the blind duplicates, suggests that both methods reported here would be suitable for the analysis of urinary AM as a biomarker for human exposure of atrazine.",
keywords = "Atrazine mercapturate, Enzyme-linked immunosorbent assay (ELISA), Human biomonitoring, Liquid chromatography-mass spectrometry (LC-MS), Online solid phase extraction, Solid phase extraction (SPE)",
author = "Koivunen, {Marja E.} and Katja Dettmer and Roel Vermeulen and Berit Bakke and Gee, {Shirley J.} and Hammock, {Bruce D.}",
year = "2006",
month = "7",
day = "21",
doi = "10.1016/j.aca.2006.05.037",
language = "English (US)",
volume = "572",
pages = "180--189",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Improved methods for urinary atrazine mercapturate analysis-Assessment of an enzyme-linked immunosorbent assay (ELISA) and a novel liquid chromatography-mass spectrometry (LC-MS) method utilizing online solid phase extraction (SPE)

AU - Koivunen, Marja E.

AU - Dettmer, Katja

AU - Vermeulen, Roel

AU - Bakke, Berit

AU - Gee, Shirley J.

AU - Hammock, Bruce D.

PY - 2006/7/21

Y1 - 2006/7/21

N2 - Elimination of interfering substances in urine by solid phase extraction (SPE) prior to analysis resulted in 10-fold improvement in the sensitivity of atrazine mercapturate (AM) enzyme-linked immunosorbent assay (ELISA) compared to previous reports. Of the two tested SPE systems, Oasis® HLB and MCX, the mixed-mode MCX gave good recoveries (82%) of AM in spiked samples measured by ELISA, whereas the reverse-phase HLB phase was not compatible with the immunochemical method. At relatively high concentrations of urinary AM (>20 ng mL-1), sample dilution was effective enough for the elimination of interfering substances. The new liquid chromatography-mass spectrometry (LC-MS) method developed for AM utilizes online-SPE with Oasis® HLB, column switching and a stable-isotope internal standard. The limit of quantification (0.05 ng mL-1) indicates improved sensitivity compared with most previously published LC-MS methods for AM. Validation of all three methods, LC-MS, ELISA + SPE and ELISA + dilution with spiked urine samples showed good correlation between the known and measured concentrations with R2 values of 0.996, 0.957 and 0.961, respectively. When a set (n = 70 plus 12 blind duplicates) of urine samples from farmers exposed to atrazine was analyzed, there was a good agreement (R2 = 0.917) between the log normalized data obtained by ELISA + SPE and LC-MS. High correlation among the data obtained by the two tested methods and the LC-MS method by the Center of Disease Control and Prevention (CDC), together with low variability among the blind duplicates, suggests that both methods reported here would be suitable for the analysis of urinary AM as a biomarker for human exposure of atrazine.

AB - Elimination of interfering substances in urine by solid phase extraction (SPE) prior to analysis resulted in 10-fold improvement in the sensitivity of atrazine mercapturate (AM) enzyme-linked immunosorbent assay (ELISA) compared to previous reports. Of the two tested SPE systems, Oasis® HLB and MCX, the mixed-mode MCX gave good recoveries (82%) of AM in spiked samples measured by ELISA, whereas the reverse-phase HLB phase was not compatible with the immunochemical method. At relatively high concentrations of urinary AM (>20 ng mL-1), sample dilution was effective enough for the elimination of interfering substances. The new liquid chromatography-mass spectrometry (LC-MS) method developed for AM utilizes online-SPE with Oasis® HLB, column switching and a stable-isotope internal standard. The limit of quantification (0.05 ng mL-1) indicates improved sensitivity compared with most previously published LC-MS methods for AM. Validation of all three methods, LC-MS, ELISA + SPE and ELISA + dilution with spiked urine samples showed good correlation between the known and measured concentrations with R2 values of 0.996, 0.957 and 0.961, respectively. When a set (n = 70 plus 12 blind duplicates) of urine samples from farmers exposed to atrazine was analyzed, there was a good agreement (R2 = 0.917) between the log normalized data obtained by ELISA + SPE and LC-MS. High correlation among the data obtained by the two tested methods and the LC-MS method by the Center of Disease Control and Prevention (CDC), together with low variability among the blind duplicates, suggests that both methods reported here would be suitable for the analysis of urinary AM as a biomarker for human exposure of atrazine.

KW - Atrazine mercapturate

KW - Enzyme-linked immunosorbent assay (ELISA)

KW - Human biomonitoring

KW - Liquid chromatography-mass spectrometry (LC-MS)

KW - Online solid phase extraction

KW - Solid phase extraction (SPE)

UR - http://www.scopus.com/inward/record.url?scp=33745727947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745727947&partnerID=8YFLogxK

U2 - 10.1016/j.aca.2006.05.037

DO - 10.1016/j.aca.2006.05.037

M3 - Article

C2 - 17723476

AN - SCOPUS:33745727947

VL - 572

SP - 180

EP - 189

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

IS - 2

ER -